Tricuspid regurgitation diagnosis and treatment

被引:137
|
作者
Arsalan, Mani [1 ,2 ,3 ]
Walther, Thomas [1 ]
Smith, Robert L., II [1 ,2 ,3 ]
Grayburn, Paul A. [1 ,2 ,3 ]
机构
[1] Kerckhoff Clin, Bad Nauheim, Germany
[2] Heart Hosp Baylor Plano, 621 N Hall St,Suite H030, Dallas, TX 75226 USA
[3] Baylor Univ, Med Ctr, 621 N Hall St,Suite H030, Dallas, TX 75226 USA
关键词
Tricuspid regurgitation; Cardiac surgery; Valvular heart disease; VALVE SURGERY; ECHOCARDIOGRAPHIC-ASSESSMENT; REAL-TIME; VALVULAR REGURGITATION; EUROPEAN ASSOCIATION; ANNULOPLASTY; HEART; REPAIR; MANAGEMENT; IMPACT;
D O I
10.1093/eurheartj/ehv487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tricuspid regurgitation (TR) is the most common lesion of the tricuspid valve (TV). Mild TR is common and usually is benign. However, moderate or severe TR can lead to irreversible myocardial damage and adverse outcomes. Despite these findings, few patients with significant TR undergo surgery. The treatment of functional (secondary) TR in particular remains controversial because of high rates of residual or recurrent TR and poor outcomes following surgical intervention. Traditional teaching that functional TR resolves on its own if the underlying disease is successfully treated has proven to be incorrect. This review aims to clarify management of TR by describing the anatomy, pathophysiology, diagnosis, and treatment of TR, including the eventual possibility of percutaneous TV therapy.
引用
收藏
页码:634 / +
页数:7
相关论文
共 50 条
  • [41] Treatment of Tricuspid Regurgitation With the FORMA Repair System
    Perlman, Gidon Y.
    Dvir, Danny
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
  • [42] Understanding Treatment Preferences for Patients with Tricuspid Regurgitation
    Iyer, Vijay
    Faza, Nadeen N.
    Pfeiffer, Michael
    Kozak, Mark
    Peterson, Brandon
    Wyler von Ballmoos, Mortiz
    Mollenkopf, Sarah
    Mancilla, Melissa
    Latibeaudiere-Gardner, Diandra
    Reardon, Michael J.
    MDM POLICY & PRACTICE, 2024, 9 (01)
  • [43] Percutaneous interventional options for the treatment of tricuspid regurgitation
    Haude, Michael
    Prendergast, Bernard
    EUROINTERVENTION, 2016, 12 : Y107 - Y107
  • [44] Clinical aspects and treatment of tricuspid valve regurgitation
    Stocker, Thomas J.
    Hausleiter, Joerg
    INNERE MEDIZIN, 2024, 65 (05): : 456 - 461
  • [45] Characteristics and treatment strategies for severe tricuspid regurgitation
    Ingraham, Brenden S.
    Pislaru, Sorin V.
    Nkomo, Vuyisile T.
    Nishimura, Rick A.
    Stulak, John M.
    Dearani, Joseph A.
    Rihal, Charanjit S.
    Eleid, Mackram F.
    HEART, 2019, 105 (16) : 1244 - 1250
  • [46] Treatment of Tricuspid Valve Regurgitation: The Future Is Now
    Nabauer, Michael
    Orban, Mathias
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (01) : 51 - 53
  • [47] Interventional catheter treatment of tricuspid valve regurgitation
    Wisst, T.
    Kreidel, F.
    Schlueter, M.
    Kuck, K. -H.
    Frerker, C.
    INTERNIST, 2017, 58 (11): : 1222 - 1230
  • [48] SURGICAL-TREATMENT OF ISOLATED TRICUSPID REGURGITATION
    YAMAZAKI, Y
    MATSUKAWA, T
    YOSHINO, T
    AKANUMA, T
    MISHINA, T
    EGUCHI, S
    IRISAWA, T
    AOKI, E
    JAPANESE JOURNAL OF THORACIC SURGERY, 1981, 34 (04): : 289 - 295
  • [49] Trillium: a new treatment for severe tricuspid regurgitation
    Cruz-Gonzalez, Ignacio
    Martin-Moreiras, Javier
    Lopez-Tejero, Sergio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (09): : 750 - 750
  • [50] The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation
    Brunner, S.
    Wolfrum, M.
    Moccetti, F.
    Stampfli, S. F.
    Attinger-Toller, A.
    Bossard, M.
    Matt, P.
    Cuculi, F.
    Kobza, R.
    Toggweiler, S.
    SWISS MEDICAL WEEKLY, 2022, 152 : 60S - 61S